These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 39099429)

  • 1. Oxytocin Protects Nigrostriatal Dopamine Signal via Activating GABAergic Circuit in the MPTP-Induced Parkinson's Disease Model.
    Wang Y; Xu H; Chen S; Chen J; Zheng Q; Ma Y; Zhao X; Shi Y; Xiao L
    Adv Sci (Weinh); 2024 Sep; 11(36):e2310244. PubMed ID: 39099429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single low doses of MPTP decrease tyrosine hydroxylase expression in the absence of overt neuron loss.
    Alam G; Edler M; Burchfield S; Richardson JR
    Neurotoxicology; 2017 May; 60():99-106. PubMed ID: 28377118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delivery of CDNF by AAV-mediated gene transfer protects dopamine neurons and regulates ER stress and inflammation in an acute MPTP mouse model of Parkinson's disease.
    Nam J; Richie CT; Harvey BK; Voutilainen MH
    Sci Rep; 2024 Jul; 14(1):16487. PubMed ID: 39019902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intranasal and subcutaneous administration of dopamine D3 receptor agonists functionally restores nigrostriatal dopamine in MPTP-treated mice.
    Lao CL; Kuo YH; Hsieh YT; Chen JC
    Neurotox Res; 2013 Nov; 24(4):523-31. PubMed ID: 23820985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotective Effects of the DPP4 Inhibitor Vildagliptin in In Vivo and In Vitro Models of Parkinson's Disease.
    Pariyar R; Bastola T; Lee DH; Seo J
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isradipine attenuates MPTP-induced dopamine neuron degeneration by inhibiting up-regulation of L-type calcium channels and iron accumulation in the substantia nigra of mice.
    Wang QM; Xu YY; Liu S; Ma ZG
    Oncotarget; 2017 Jul; 8(29):47284-47295. PubMed ID: 28521299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small molecule TrkB agonist deoxygedunin protects nigrostriatal dopaminergic neurons from 6-OHDA and MPTP induced neurotoxicity in rodents.
    Nie S; Xu Y; Chen G; Ma K; Han C; Guo Z; Zhang Z; Ye K; Cao X
    Neuropharmacology; 2015 Dec; 99():448-58. PubMed ID: 26282118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased susceptibility of G-protein coupled receptor 6 deficient mice to MPTP neurotoxicity.
    Oeckl P; Ferger B
    Neuroscience; 2016 Nov; 337():218-223. PubMed ID: 27651149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The TrkB-positive dopaminergic neurons are less sensitive to MPTP insult in the substantia nigra of adult C57/BL mice.
    Ding YX; Xia Y; Jiao XY; Duan L; Yu J; Wang X; Chen LW
    Neurochem Res; 2011 Oct; 36(10):1759-66. PubMed ID: 21562748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic deprivation of TrkB signaling leads to selective late-onset nigrostriatal dopaminergic degeneration.
    Baydyuk M; Nguyen MT; Xu B
    Exp Neurol; 2011 Mar; 228(1):118-25. PubMed ID: 21192928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intervention with exercise restores motor deficits but not nigrostriatal loss in a progressive MPTP mouse model of Parkinson's disease.
    Sconce MD; Churchill MJ; Greene RE; Meshul CK
    Neuroscience; 2015 Jul; 299():156-74. PubMed ID: 25943481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gait Deficits and Loss of Striatal Tyrosine Hydroxlase/Trk-B are Restored Following 7,8-Dihydroxyflavone Treatment in a Progressive MPTP Mouse Model of Parkinson's Disease.
    Massaquoi MS; Liguore WA; Churchill MJ; Moore C; Melrose HL; Meshul CK
    Neuroscience; 2020 May; 433():53-71. PubMed ID: 32142862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combining nitric oxide release with anti-inflammatory activity preserves nigrostriatal dopaminergic innervation and prevents motor impairment in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.
    L'Episcopo F; Tirolo C; Caniglia S; Testa N; Serra PA; Impagnatiello F; Morale MC; Marchetti B
    J Neuroinflammation; 2010 Nov; 7():83. PubMed ID: 21092260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of ghrelin on the motor deficit caused by the ablation of nigrostriatal dopaminergic cells or the inhibition of striatal dopamine receptors.
    Suda Y; Kuzumaki N; Narita M; Hamada Y; Shibasaki M; Tanaka K; Tamura H; Kawamura T; Kondo T; Yamanaka A; Narita M
    Biochem Biophys Res Commun; 2018 Feb; 496(4):1102-1108. PubMed ID: 29378186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tyrosine hydroxylase expression and activity in nigrostriatal dopaminergic neurons of MPTP-treated mice at the presymptomatic and symptomatic stages of parkinsonism.
    Kozina EA; Khakimova GR; Khaindrava VG; Kucheryanu VG; Vorobyeva NE; Krasnov AN; Georgieva SG; Kerkerian-Le Goff L; Ugrumov MV
    J Neurol Sci; 2014 May; 340(1-2):198-207. PubMed ID: 24768159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benfotiamine protects MPTP-induced Parkinson's disease mouse model via activating Nrf2 signaling pathway.
    Wang K; Han C; Yang J; Xu W; Wang L; Li H; Wang Y
    PLoS One; 2024; 19(7):e0307012. PubMed ID: 39042624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ursolic acid attenuates oxidative stress in nigrostriatal tissue and improves neurobehavioral activity in MPTP-induced Parkinsonian mouse model.
    Rai SN; Yadav SK; Singh D; Singh SP
    J Chem Neuroanat; 2016 Jan; 71():41-9. PubMed ID: 26686287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen reduces BDNF level, but maintains dopaminergic cell density in the striatum of MPTP mouse model.
    Tripanichkul W; Gerdprasert O; Jaroensuppaperch EO
    Int J Neurosci; 2010 Jul; 120(7):489-95. PubMed ID: 20583901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective properties of icariin in MPTP-induced mouse model of Parkinson's disease: Involvement of PI3K/Akt and MEK/ERK signaling pathways.
    Chen WF; Wu L; Du ZR; Chen L; Xu AL; Chen XH; Teng JJ; Wong MS
    Phytomedicine; 2017 Feb; 25():93-99. PubMed ID: 28190476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of miR-124 in MPTP-treated mouse model of Parkinson's disease and MPP iodide-treated MN9D cells modulates the expression of the calpain/cdk5 pathway proteins.
    Kanagaraj N; Beiping H; Dheen ST; Tay SS
    Neuroscience; 2014 Jul; 272():167-79. PubMed ID: 24792712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.